Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

Hepatitis E is a liver infection caused by the hepatitis E virus (HEV), which can lead to acute hepatitis and chronic complications in immunocompromised individuals. According to Sidra Urooj et al. (2023), the infection results in 0.5%-3% terminal illness among young adults, rising to 30% in pregnant women. As per the hepatitis E epidemiology forecast by Expert Market Research, disease burden trends inform epidemiological assessment and viral hepatitis research.

2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

Hepatitis E – Number of Cases by Year

Read more about this report - Request a Free Sample

Hepatitis E Epidemiology Forecast Report Coverage

Expert Market Research's “Hepatitis E Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of hepatitis E. It projects the future incidence and prevalence rates of hepatitis E cases across various populations. The study covers age, gender, and type as major determinants of the hepatitis E population. The report highlights patterns in the prevalence of hepatitis E over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of hepatitis E in the 8 major markets.

Regions Covered

  • United States
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

Hepatitis E Understanding: Disease Overview

Hepatitis E is a liver infection caused by the hepatitis E virus (HEV), primarily transmitted through the fecal-oral route, particularly by consuming water contaminated with human waste. Infections can also occur through undercooked meat from infected animals, including pigs and wild boar. The disease is generally acute and self-limiting, although chronic infection can develop in immunocompromised individuals. Genotypes 1 and 2 primarily affect humans, whereas genotypes 3 and 4 are associated with zoonotic transmission. Viral hepatitis can cause fatigue, nausea, abdominal discomfort, and jaundice.

Key Report Insights

Parameter

Insight

Largest Patient Pool

India

Fastest Growing Country

India

High-Risk Population

Pregnant women, particularly those in the second or third trimester, immunocompromised individuals, and people with preexisting liver disease.

Key Diagnostic Method

Anti-HEV IgM antibody testing; HEV RNA testing can help confirm active infection, particularly in immunocompromised patients.

Major Risk Factor

Consumption of water contaminated with fecal matter, inadequate sanitation, and consumption of undercooked infected meat.

Major gap in the market

Underdiagnosis and underreporting, limited access to reliable diagnostic testing in some settings, and gaps in surveillance and preventive infrastructure.

Hepatitis E Epidemiology Perspective

The hepatitis E epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the hepatitis E epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for hepatitis E and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Epidemiology Segment

Key Insights

Diagnosed Prevalent Cases of the Disease

According to K. Parameswari et al. (2025), hepatitis E virus (HEV) was detected in 2.49% of patients presenting with suspected acute viral hepatitis at a tertiary care hospital in Guntur, Andhra Pradesh, during January-June 2024.

Gender-Specific Cases of the Disease

As per the Indian Journal of Microbiology Research (2024), males accounted for 57.1% of HEV-reactive patients, compared with 42.0% among females, in a retrospective study of acute viral hepatitis cases in Himachal Pradesh, India.

Age-Specific Cases of the Disease

According to the Indian Journal of Microbiology Research (2024), HEV infection was observed only among adults in the Himachal Pradesh study, with the highest prevalence in individuals aged 21-30 years.

Ethnicity-Wise Cases of the Disease

As per María Belén Pisano et al. (2022), HEV IgG seroprevalence in the United States was higher among non-Hispanic Asian individuals and people born outside the country, indicating differences in exposure across population groups.

Mortality and Survival Analysis of the Disease

According to Sidra Urooj et al. (2023), HEV infection results in terminal illness in approximately 0.5%-3% of young adults, with the proportion increasing to 30% among pregnant women.

Type-Specific Disease Burden and Epidemiology Analysis

Disease Type

Prevalence

Hepatitis E virus genotype 1

According to Heli Harvala et al. (2022), genotype 1 is associated with waterborne outbreaks, particularly in developing countries.

Hepatitis E virus genotype 2

As per Heli Harvala et al. (2022), genotype 2 primarily infects humans and has been associated with large waterborne outbreaks in developing countries.

Hepatitis E virus genotype 3

According to Heli Harvala et al. (2022), genotype 3 is associated with domestic pigs and other animal reservoirs, contributing to locally acquired human infections in Europe, North America, and Japan.

Hepatitis E virus genotype 4

As per Heli Harvala et al. (2022), genotype 4 circulates in pigs and other animal reservoirs and is associated with human infections in China and other parts of Southeast Asia.

Hepatitis E – Number of Cases by Country

Read more about this report - Request a Free Sample

Country-wise Hepatitis E Epidemiology

The hepatitis E epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Country

Key Insights

United States

According to María Belén Pisano et al. (2022), HEV seroprevalence in the United States was 6.1% for immunoglobulin G (IgG) and 1.02% for immunoglobulin M (IgM) during 2009-2016. IgG seroprevalence was higher among older people, females, non-Hispanic Asian individuals, and people born outside the United States.

Germany

In Germany, hepatitis E transmission is associated with locally acquired zoonotic infections involving HEV genotype 3, with domestic pigs and wild boars serving as important animal reservoirs. Consumption of undercooked pork, wild boar meat, and related meat products contributes to exposure. Increased diagnostic testing and disease surveillance may also contribute to rising reported case numbers. According to Heli Harvala et al. (2022), genotype 3 is associated with animal reservoirs and foodborne transmission in developed countries.

France

According to Marie Pellerin et al. (2022), HEV seroprevalence among individual pigs in France has been reported at 31% and 60% in separate studies. Additionally, 3%-4% of pork livers collected at slaughterhouses tested positive for HEV RNA. These findings indicate circulation of HEV in animal reservoirs and pork products.

Italy

In Italy, hepatitis E transmission is associated with consumption of undercooked pork and sausages, as well as exposure through shellfish and locally circulating HEV genotype 3. Environmental circulation of HEV has also been documented in urban wastewater. According to the Italian national surveillance study published in 2018, undercooked pork and pork sausages were prominent reported risk factors among genotype 3 cases, alongside evidence of environmental circulation.

Spain

In Spain, hepatitis E epidemiology is characterized by the circulation of HEV genotype 3, particularly subtype 3f, which has been identified across the country's autonomous communities. Animal reservoirs and potential foodborne exposure are relevant to the transmission of this zoonotic genotype. According to the Spanish Reference Laboratory surveillance study covering 2009-2019, genotype 3 was detected in 291 samples, and subtype 3f accounted for 88.3% of these detections.

United Kingdom

According to Heli Harvala et al. (2022), HEV antibody seroprevalence in the United Kingdom ranges from 5% to 13%. This range reflects previous exposure to the virus rather than the rate of new infections. The findings also highlight the importance of genotype 3 and animal-associated transmission in developed countries.

Japan

According to Tatsuo Kanda et al. (2024), anti-HEV immunoglobulin G was detected in 2.9% of 1,893 liver transplant recipients, while HEV RNA was detected in 0.12% of 1,651 tested recipients. The review also reports that nationwide nucleic acid amplification testing of blood products began in 2020 following concerns about transfusion-associated HEV infection.

India

According to the Indian Journal of Microbiology Research (2024), HEV seroprevalence was 1.8% among 784 serum samples from patients evaluated for acute viral hepatitis in Himachal Pradesh. Males accounted for 57.1% of HEV-reactive patients, and the highest prevalence occurred among adults aged 21-30 years. According to K. Parameswari et al. (2025), HEV was detected in 2.49% of suspected cases in a Guntur hospital study conducted from January to June 2024.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

Hepatitis E presents opportunities to strengthen disease surveillance, improve diagnostic access, and expand public health interventions across the United States, Germany, France, Italy, Spain, the United Kingdom, Japan, and India. A key epidemiological gap is underrecognition of sporadic and locally acquired infections, particularly where testing is not routinely performed. India offers opportunities to improve safe water access, sanitation, and outbreak monitoring, while developed countries could benefit from greater clinical awareness of zoonotic transmission and infections among immunocompromised individuals. Improved laboratory testing and standardized reporting could support earlier detection and more accurate disease burden assessment.

Hepatitis E: Treatment Overview

Hepatitis E treatment primarily involves supportive care because most acute infections resolve spontaneously without specific antiviral therapy. Patients are advised to maintain adequate hydration, consume a balanced diet, and rest as needed. Alcohol and potentially liver-toxic medications should be avoided or reviewed by a healthcare professional. Severe cases, particularly those involving acute liver failure or infection during pregnancy, require prompt medical evaluation and potentially hospital-based management. In selected cases of chronic hepatitis E among immunocompromised patients, reducing immunosuppression may help clear the infection, while ribavirin may be considered under specialist supervision.

Key Questions Answered

  • What is the current and projected burden of hepatitis E across the 8 major markets?
  • Which countries across the 8 major markets account for the highest hepatitis E patient populations and fastest growth rates?
  • What is the diagnosed versus undiagnosed patient population of hepatitis E across key countries in the 8 major markets?
  • Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of hepatitis E across the 8 major markets?
  • What are the major drivers contributing to the increasing burden of hepatitis E across the 8 major markets?
  • How do major comorbidities and risk factors influence hepatitis E epidemiology trends across the 8 major markets?
  • What are the regional trends in advanced disease progression, treatment uptake, and patient management of hepatitis E across the 8 major markets?
  • Which patient segments represent the highest unmet clinical need in the hepatitis E landscape across the 8 major markets?
  • Which therapeutic areas linked to hepatitis E are expected to witness the strongest growth opportunities across the 8 major markets?
  • How is the hepatitis E epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
  • Which countries across the 8 major markets offer the most attractive market opportunities based on hepatitis E epidemiology and healthcare infrastructure?
  • Which epidemiological trends are expected to influence future drug development and market access strategies for hepatitis E across the 8 major markets?

Scope of the Hepatitis E Epidemiology Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of hepatitis E based on several factors.
  • Hepatitis E Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The hepatitis E report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Hepatitis E Diagnostic Tests Market

Chronic Hepatitis Delta Virus (HDV) Infection Pipeline Analysis

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2025

Historical Period

2019-2025

Forecast Period

2026-2035

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • Japan
  • India

Datasheet

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Datasheet

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us